Derivation and validation of an artificial intelligence-based plaque burden safety cut-off for long-term acute coronary syndrome from coronary computed tomography angiography

dc.contributor.authorBar, Sarah
dc.contributor.authorKnuuti, Juhani
dc.contributor.authorSaraste, Antti
dc.contributor.authorKlen, Riku
dc.contributor.authorKero, Tanja
dc.contributor.authorNabeta, Takeru
dc.contributor.authorBax, Jeroen J.
dc.contributor.authorDanad, Ibrahim
dc.contributor.authorNurmohamed, Nick S.
dc.contributor.authorJukema, Ruurt A.
dc.contributor.authorKnaapen, Paul
dc.contributor.authorMaaniitty, Teemu
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.converis.publication-id498482701
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/498482701
dc.date.accessioned2025-08-27T22:40:08Z
dc.date.available2025-08-27T22:40:08Z
dc.description.abstract<p><strong>Aims</strong><br>Artificial intelligence (AI) has enabled accurate and fast plaque quantification from coronary computed tomography angiography (CCTA). However, AI detects any coronary plaque in up to 97% of patients. To avoid overdiagnosis, a plaque burden safety cut-off for future coronary events is needed.</p><p><strong>Methods and results</strong><br>Percent atheroma volume (PAV) was quantified with AI-guided quantitative computed tomography in a blinded fashion. Safety cut-off derivation was performed in the Turku CCTA registry (Finland), and pre-defined as ≥90% sensitivity for acute coronary syndrome (ACS). External validation was performed in the Amsterdam CCTA registry (the Netherlands). In the derivation cohort, 100/2271 (4.4%) patients experienced ACS (median follow-up 6.9 years). A threshold of PAV ≥ 2.6% was derived with 90.0% sensitivity and negative predictive value (NPV) of 99.0%. In the validation cohort 27/568 (4.8%) experienced ACS (median follow-up 6.7 years) with PAV ≥ 2.6% showing 92.6% sensitivity and 99.0% NPV for ACS. In the derivation cohort, 45.2% of patients had PAV < 2.6 vs. 4.3% with PAV 0% (no plaque) (P < 0.001) (validation cohort: 34.3% PAV < 2.6 vs. 2.6% PAV 0%; P < 0.001). Patients with PAV ≥ 2.6% had higher adjusted ACS rates in the derivation [Hazard ratio (HR) 4.65, 95% confidence interval (CI) 2.33–9.28, P < 0.001] and validation cohort (HR 7.31, 95% CI 1.62–33.08, P = 0.010), respectively.</p><p><strong>Conclusion</strong><br>This study suggests that PAV up to 2.6% quantified by AI is associated with low-ACS risk in two independent patient cohorts. This cut-off may be helpful for clinical application of AI-guided CCTA analysis, which detects any plaque in up to 96–97% of patients.</p>
dc.identifier.eissn2047-2412
dc.identifier.jour-issn2047-2404
dc.identifier.olddbid202580
dc.identifier.oldhandle10024/185607
dc.identifier.urihttps://www.utupub.fi/handle/11111/47651
dc.identifier.urlhttps://doi.org/10.1093/ehjci/jeaf121
dc.identifier.urnURN:NBN:fi-fe2025082785769
dc.language.isoen
dc.okm.affiliatedauthorBär, Sarah
dc.okm.affiliatedauthorKnuuti, Juhani
dc.okm.affiliatedauthorSaraste, Antti
dc.okm.affiliatedauthorKlén, Riku
dc.okm.affiliatedauthorMaaniitty, Teemu
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherOXFORD UNIV PRESS
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.publisher.placeOXFORD
dc.relation.articlenumberjeaf121
dc.relation.doi10.1093/ehjci/jeaf121
dc.relation.ispartofjournalEHJ Cardiovascular Imaging / European Heart Journal - Cardiovascular Imaging
dc.source.identifierhttps://www.utupub.fi/handle/10024/185607
dc.titleDerivation and validation of an artificial intelligence-based plaque burden safety cut-off for long-term acute coronary syndrome from coronary computed tomography angiography
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
jeaf121.pdf
Size:
748.9 KB
Format:
Adobe Portable Document Format